Key facts
- This page summarizes Harry Skip Kiil's Form 4 filing for Medtronic plc (MDT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2026, 16:17.
Harry Skip Kiil - 16 Sep 2026 Form 4 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP & President Cardiovascular
- Issuer ticker
- MDT
- Reported as of
- 16 Sep 2026
- Net transaction value
- -$138,883
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 16:17:44 UTC
- Prior SEC filing
- 04 Aug 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patricia Walesiewicz, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Harry Skip Kiil filed Form 4 for Medtronic plc (MDT) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 04 Aug 2026.
- Current net transaction value: -$138,883.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001708062
Primary reporting owner
KIIL HARRY SKIP
- Relationship
- EVP & President Cardiovascular
- Address
- 710 MEDTRONIC PARKWAY, MINNEAPOLIS
- Signature
- /s/ Patricia Walesiewicz, attorney-in-fact
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
transaction
Ordinary Shares
Sale
- Transaction value
- $138,883
- Shares
- -1,483
- Change %
- -3.4%
- Price
- $93.65
- Shares after
- 42,186
- Date
- 16 Sep 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.